Related by context. Frequent words. (Click for all words.) 59 CYPHER ® Stent 58 Taxus Stent 58 PREZISTA r 58 carotid artery stenting 58 plus prednisone 58 liver transplant recipients 58 active comparator 57 placebo controlled clinical 57 ischemic cardiomyopathy 57 randomized controlled clinical trials 57 RRMS patients 57 tolvaptan 57 coronary revascularization 57 chemoradiotherapy 56 TAXUS stent 56 Amrubicin 56 relapsed refractory multiple myeloma 56 heavily pretreated 56 PRECiSE 56 paclitaxel eluting stent 56 blinded placebo controlled 56 goserelin 55 prospective multicenter 55 neoadjuvant 55 placebo controlled clinical trials 55 plus dexamethasone 55 retrospective cohort study 55 multicenter clinical 55 prospective observational 55 events SAEs 55 placebo controlled Phase 55 double blinded placebo 55 placebo controlled studies 55 relapsed multiple myeloma 55 atherothrombosis 55 multicentre 55 acute myocardial infarction AMI 55 multicenter 54 multicenter randomized 54 Secondary endpoints 54 SPIRIT III 54 randomized Phase III 54 randomized controlled clinical 54 chronic HCV infection 54 TAXUS Element Stent 54 COPAXONE R 54 sustained virologic response 54 superficial bladder cancer 54 peginterferon alfa 2b 53 acute coronary syndromes ACS 53 prospective randomized 53 mg QD 53 CYPHER R Stent 53 undergoing coronary artery 53 paclitaxel chemotherapy 53 plus gemcitabine 53 plus methotrexate 53 multicenter randomized double 53 ADHF 53 NLX P# 53 retrospectively reviewed 53 prospective randomized controlled 53 placebo controlled trials 53 RTOG 53 virologic response 53 carboplatin paclitaxel 53 metastatic hormone refractory 53 randomized clinical trials 53 Fludara 53 placebo controlled randomized 53 ponatinib 53 mg kg dose 53 vinorelbine 53 Traficet EN 53 seroprotection 53 Azedra 52 omecamtiv mecarbil 52 randomized clinical 52 placebo controlled 52 discontinuations due 52 decitabine 52 neoadjuvant chemotherapy 52 Imprime PGG 52 lipid lowering therapy 52 mg BID 52 daunorubicin 52 Secondary endpoints include 52 chlorambucil 52 androgen deprivation 52 randomized controlled 52 HER2 positive metastatic breast 52 RECIST criteria 52 mRCC 52 dacarbazine 52 peg IFN 52 nitazoxanide 52 Thrombolysis 52 diabetic neuropathic pain 52 GSK# [001] 52 axitinib 52 azacitidine